-
PROVIDERS
REGISTER NOW
Upcoming Webinar:
MRD data insights across the cancer care continuum -
LIFE SCIENCES
REGISTER NOW
From insight to impact: Leveraging the AI-enabled Next platform with BMS to advance equitable access in precision oncology
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
04/21/2026
Tempus Next Pathways unlocked critical insights into the aNSCLC patient journey with Bristol Myers Squibb (BMS)
Discover how BMS collaborated with Tempus to deploy the Next Pathways program across 13 community-based health systems to address care gaps for patients with advanced non-small cell lung cancer (aNSCLC).
-
04/03/2026Utilizing real-world external controls for regulatory decision-making
A biotech company needed to contextualize its Phase 1b/2a trial for mNSCLC patients with a specific mutation. Learn how Tempus constructed a real-world external control arm to provide a benchmark for their regulatory submission.
Read more -
03/24/2026Translating data into an actionable R&D strategy
Hear from industry leaders about how a data-driven understanding of disease biology informs critical decisions and accelerates therapeutic development. Secure your recording now.
Watch replay -
03/09/2026From model to medicine: Closing the preclinical to clinical gap with an integrated, data-driven engine
Richard Klinghoffer, SVP and Head of Systems Biology at Tempus, discusses how preclinical models can be disconnected from real patient biology, contributing to challenges in oncology drug development.
Read more
Assess your cohort’s feasibility with our RWD
Submit your preliminary criteria, and our team will provide a tailored feasibility assessment to help accelerate your research goals.*